On June 4, 2018 5:00 pm ET Dr. Axelrod will be answering your questions. Dr. Deborah Axelrod is currently the Director of Clinical Breast Services and Breast Surgery, Medical Director of Community Cancer Education and Outreach at NYU's Clinical Cancer, and a Board-certified surgeon specializing in breast diseases and breast cancer. Ask your questions below and we will make sure they get answered. Be sure to also post your questions on the live thread on June 4th where Dr. Axelrod will answer them directly.
What questions do you have for Dr. Ax... - SHARE Breast Canc...
What questions do you have for Dr. Axelrod "Ask a Breast Surgeon"?
![dandrews profile image](https://images.hu-production.be/avatars/b28eb4523dc520539d73f6b1f00a7009_small@2x_100x100.jpg)
![](https://images.hu-production.be/post/post_75a55a50ad684643819f45d29986ef9a_636632884576220000.jpg)
![dandrews profile image](https://images.hu-production.be/avatars/b28eb4523dc520539d73f6b1f00a7009_small@2x_100x100.jpg)
The ability to reply to this post has been turned off.
Followup recommendations for ILC seem to vary, especially when it comes to what type of scans to have. What are the current recommendations? And what should be done when the type scan/test recommended did not initially detect one’s ILC? Also, should Followup continue for a longer period for ILC, say 10-20 years?
Are most Targeted medications like Ibrance and Verzenio the same? Just different drug companies that make them? Thank you!
What are the questions one should ask and have answered when deciding whether to have a mastectomy or lumpectomy?
A while back it was reported in the news that women who’d had reconstruction with textured implants had an increased risk of developing lymphoma. Do you think women who currently have textured implants should consider having them removed? Does the risk get less over time? I’ve had these kind of implants since 2007.
The ability to reply to this post has been turned off.